CDIX - Cardiff Lexington Opens 12th Nova Ortho and Spine Location in Orlando Florida

Orlando location establishes key presence in major population center in Florida

LEXINGTON, KY / ACCESSWIRE / July 29, 2024 / Cardiff Lexington Corporation (OTC Pink:CDIX) today announced the opening of a new location of Nova Ortho and Spine in Orlando, Florida. Opening Monday August 5, this is the 12^th total Nova Ortho and Spine location and the 11^th in the state of Florida.

Nova Ortho and Spine provides traumatic injury victims with diagnostic and surgical services for their injuries, with revenue primarily derived from bodily injury, general liability, and personal injury protection policies. The Company's new 1,600 square foot facility at 1900 North Mills Avenue, Suite 101 in Orlando is located in a major population hub in Florida, significantly enhancing visibility and patient access in this part of the state.

Alex Cunningham, CEO of Cardiff Lexington, commented, "With over 300,000 residents, Orlando is the fourth largest city in the state of Florida by population. We have built a strong presence across smaller key markets, and we're pleased to be taking this next step as we expand into larger metropolitan areas that significantly enhance our visibility and patient access. The opening of this facility is in line with our growth strategy as we continue to expand our network of locations throughout Florida, while also evaluating opportunities to expand into the broader Southeast United States."

Dr. Kevin Fitzgerald, Managing Director of Nova Ortho and Spine, commented, "We're very pleased to be opening our 12^th Nova Ortho and Spine location in Orlando, Florida, and providing access to essential orthopedic care and services to the many people that call this area home. With our strong referral source and incredible patient satisfaction ratings, opening a location in Orlando was an easy decision. We will continue to deliver the highest quality medical care while maintaining our personal touch in this vibrant, high-volume market."

About Cardiff Lexington Corporation:

Cardiff Lexington Corporation is a holding company focused on locating, acquiring, and building middle market, niche companies, primarily in the healthcare industry. Fundamental to the Cardiff Lexington strategy is the service-based partnership culture which emphasizes core values, teamwork, accountability, and performance.

A substantial majority of the Company's revenue is derived from Nova Ortho and Spine, LLC, which operates a group of regional primary specialty and ancillary care facilities throughout Florida and in Georgia that provide traumatic injury victims with a full range of diagnostic and surgical services, primary care evaluations, interventional pain management, and specialty consultation services.

For more information on Cardiff Lexington Corporation, you may access the company's website at https://cardifflexington.com/

FORWARD LOOKING STATEMENTS

This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management's beliefs, assumptions, and expectations of the Company's future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although the Company believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. The Company does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. Forward-looking statements are subject to a number of factors, risks, and uncertainties, some of which are not currently known to us, that may cause the Company's actual results, performance, or financial condition to be materially different from the expectations of future results, performance, or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in "Risk Factors" included in our filings with the Securities and Exchange Commission.

CONTACT:

Cardiff Lexington Investor Relations
investorsrelations@cardifflexington.com
(800) 628-2100 ext. 705
or
IMS Investor Relations
cardifflexington@imsinvestorrelations.com
(203) 972-9200

SOURCE: Cardiff Lexington Corporation